<DOC>
	<DOCNO>NCT02144441</DOCNO>
	<brief_summary>This study examine feasibility implement clinician-supported patient self-managed inpatient insulin intervention . It : assess number eligible patient present time ; assess patient ' willingness enroll ; assess patient ' ability successfully complete intervention ; examine occurrence hyperglycemia hypoglycemia ; assess patient ' satisfaction inpatient diabetes care .</brief_summary>
	<brief_title>Pilot Study Clinician-supported Patient Self-management Hospital Insulin Therapy</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Admitted Hospital University Pennsylvania ( HUP ) past 72 hour . Current HUP locations Founders 12 , Founders 14 , Silverstein 11 , Rhoads 1 . Age 18 year old . Type1 type2 diabetes mellitus require home basalbolus insulin therapy administer via subcutaneous injection ( pump ) . Patient manages basalbolus insulin therapy home without assistance , include measure blood glucose ( least mealtime ) administer subcutaneous insulin . Patient willing use follow insulin product : rapidacting insulin aspart via insulin pen ( NovoLog ) longacting insulin glargine via vial syringe ( Lantus ) . Most recent hemoglobin A1c measure within past 6 month &lt; 7.5 % . Active order inhospital basalbolus slidingscale insulin . Patient willing able record selfmeasured blood glucose result , dose insulin selfadminister , food journal , exercise log . Clinical care team agree study inclusion . Inpatient order insulin via subcutaneous infusion ( i.e. , pump ) intravenous infusion ( i.e. , drip ) . Inability perform activity require trial . Primary reason admission hyperglycemia , hypoglycemia , diabetic ketoacidosis , hyperglycemic hyperosmolar nonketotic coma , psychiatric condition , acute alcohol poisoning , acute drug ingestion . Order newlyprescribed increase dose previouslyprescribed corticosteroid . Enteral parenteral nutrition . Expected length stay &lt; 48h , determine treat physician . At risk selfharm , determine 1to1 status placement . Pregnant , record medical record . Can understand , speak , read English . Patient wish utilize Novolog Lantus hospital . Prior enrollment trial . Do resuscitate status . Inability give write informed consent . Clinical care team disagree study inclusion . Patient limit mobility safely access bedside medication lockbox .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Insulin</keyword>
	<keyword>Self Administration</keyword>
	<keyword>Patient Satisfaction</keyword>
	<keyword>Glucose</keyword>
	<keyword>Hypoglycemia</keyword>
	<keyword>Hyperglycemia</keyword>
</DOC>